You can Support Project Access today!

Blog

Oct 17

Contraceptive Pearl: Practices of Consent and Autonomy for Patients with Disabilities, Part 2

Written by Maddie Fowler, Spark Dariy, Amy Stone Last month’s Pearl discussed key practices of consent. Here, we share unique considerations for those with physical disabilities, intellectual and developmental disabilities (IDD) or cognitive impairment, non-speaking patients, and deaf patients. Physical Disability People with physical disabilities may require additional assistance during the exam. Without making assumptions,…

Sep 19

Contraceptive Pearl: Practices of Consent and Autonomy for Patients with Disabilities, Part 1

Written by Maddie Fowler, Spark Dariy, Amy Stone Many disabled people have been systematically disempowered and taught to prioritize compliance over self-advocacy. People with disabilities experience sexual assault at over three times the rate of nondisabled people, rising to seven times the rate in people with intellectual and developmental disabilities (IDD).¹ Therefore, it is critical…

Aug 22

Insights: Self-Care Support Practices in Abortion

Written by Rachna Vanjani Counseling around abortion has traditionally centered around options counseling and medical facts; patients typically receive information about the steps of the abortion, side effects, risks, and what to expect in terms of bleeding, cramping, and pain. Holistic care around mental, emotional, and spiritual well-being during and after an abortion should also…

Aug 15

Post-Abortion Self-Care Card

This 4.25″ x 5.5″ card offers a holistic lens to counseling and provides patients with information on how to care for themselves during or after an abortion with a focus on time, space, support, nourishment, and mindfulness. The card also provides a music playlist featuring BIPOC artists and a “RAIN” meditation. Art by Priya Handa,…

Aug 15

Contraceptive Pearl: Discussing the Contraceptive Patch and BMI

Written by Angeline Ti Two contraceptive patches are currently available in the United States: one containing norelgestromin (NGMN) 150 mcg/day with ethinyl estradiol (EE) 35 mcg/day (Xulane1 or the generic Zafemy2) and a newer one containing levonorgestrel (LNG) 120 mcg/day and EE 30 mcg/day (Twirla3). When prescribing the patch for patients with larger bodies, there…